$ANKM
Ankam, Inc.

2024 Q3 Form 10-Q Financial Statement

#000178162924000014 Filed on July 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $8.697K $15.39K $10.60K
YoY Change 44.97% 45.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $29.15K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization -$13.47K
YoY Change
% of Gross Profit
Operating Expenses $79.10K $87.21K $75.47K
YoY Change 5.46% 15.55% 1053.68%
Operating Profit -$70.40K
YoY Change 2.03%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $44.93K $44.90K $44.90K
YoY Change 0.06% 0.0%
Pretax Income $83.91K -$71.83K -$64.88K
YoY Change -221.59% 10.72% -1091.68%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $83.91K -$71.83K -$64.88K
YoY Change -221.59% 10.72% 891.68%
Net Earnings / Revenue 964.76% -466.87% -612.15%
Basic Earnings Per Share $0.01 -$0.02 -$0.02
Diluted Earnings Per Share $0.01 -$0.02
COMMON SHARES
Basic Shares Outstanding 4.328M shares 4.328M shares 4.328M shares
Diluted Shares Outstanding 4.558M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.070K
YoY Change
Cash & Equivalents $19.19K $1.069K $3.956K
Short-Term Investments
Other Short-Term Assets $70.41K
YoY Change
Inventory
Prepaid Expenses $30.00K $46.85K $10.00K
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $59.74K $71.48K $93.91K
YoY Change 7.62% -23.89% -42.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $117.7K $130.9K $255.2K
YoY Change -52.59% -48.73% 321.11%
TOTAL ASSETS
Total Short-Term Assets $59.74K $71.48K $93.91K
Total Long-Term Assets $117.7K $130.9K $255.2K
Total Assets $177.4K $202.3K $349.2K
YoY Change -41.59% -42.05% 55.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $268.0K
YoY Change
Accrued Expenses $5.800K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $427.3K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $471.3K $718.2K $541.9K
YoY Change -16.65% 32.54% 132.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $471.3K $718.2K $541.9K
Total Long-Term Liabilities $0.00
Total Liabilities $471.3K $718.2K $541.9K
YoY Change -16.65% 32.54% 132.97%
SHAREHOLDERS EQUITY
Retained Earnings -$467.5K -$551.4K $228.3K
YoY Change -257.26% -341.55% 430.16%
Common Stock $4.558K $4.328K
YoY Change 5.31% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$293.9K -$515.8K -$192.7K
YoY Change
Total Liabilities & Shareholders Equity $177.4K $202.3K $349.2K
YoY Change -41.59% -42.05% 55.1%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income $83.91K -$71.83K -$64.88K
YoY Change -221.59% 10.72% 891.68%
Depreciation, Depletion And Amortization -$13.47K
YoY Change
Cash From Operating Activities -$87.98K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $131.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $26.64K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 61.71K
YoY Change
NET CHANGE
Cash From Operating Activities -87.98K
Cash From Investing Activities 26.64K
Cash From Financing Activities 61.71K
Net Change In Cash 370.0
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$87.98K
Capital Expenditures $131.4K
Free Cash Flow -$219.4K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei City Area Code
CityAreaCode
361
dei Local Phone Number
LocalPhoneNumber
2325001
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q2 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
usd
CY2023Q2 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
usd
CY2023 us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-05-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-255392
dei Entity Registrant Name
EntityRegistrantName
ANKAM, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1900749
dei Entity Address Address Line1
EntityAddressAddressLine1
5348 Vegas Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89108
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4327996 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1069 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
286 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21390 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
46846 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15847 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23564 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
48643 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
71479 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
86166 usd
CY2024Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
130866 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
22157 usd
CY2024Q2 us-gaap Assets
Assets
202345 usd
CY2023Q4 us-gaap Assets
Assets
108323 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
268040 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
84000 usd
CY2024Q2 us-gaap Deferred Revenue
DeferredRevenue
17005 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
12700 usd
CY2024Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
427343 usd
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
292026 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5801 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44900 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
718189 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
433626 usd
CY2024Q2 us-gaap Liabilities
Liabilities
718189 usd
CY2023Q4 us-gaap Liabilities
Liabilities
433626 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4327996 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4327996 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4327996 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4327996 shares
CY2024Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
4328
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
4328
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31262 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31262 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-551434 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-360893 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-515844 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-325303 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
202345 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108323 usd
CY2024Q2 us-gaap Revenues
Revenues
15385 usd
CY2023Q2 us-gaap Revenues
Revenues
10598 usd
us-gaap Revenues
Revenues
25145 usd
us-gaap Revenues
Revenues
13698 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
82 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26822 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
167 usd
CY2024Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
24000 usd
CY2023Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
18000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
46000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
36000 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
5057 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
5516 usd
us-gaap Professional Fees
ProfessionalFees
30378 usd
us-gaap Professional Fees
ProfessionalFees
20333 usd
CY2024Q2 us-gaap Other Expenses
OtherExpenses
44898 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
44898 usd
us-gaap Other Expenses
OtherExpenses
89796 usd
us-gaap Other Expenses
OtherExpenses
89796 usd
CY2024Q2 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
13170 usd
CY2023Q2 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
6978 usd
us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
22691 usd
us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
13955 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
87213 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
75474 usd
us-gaap Operating Expenses
OperatingExpenses
215687 usd
us-gaap Operating Expenses
OperatingExpenses
160251 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-71828 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-64876 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-190542 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-146553 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-71828 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-64876 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-190542 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-146553 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-71828 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-64876 usd
us-gaap Net Income Loss
NetIncomeLoss
-190542 usd
us-gaap Net Income Loss
NetIncomeLoss
-146553 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4327996 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4327996 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4327996 shares
CY2022Q4 us-gaap Shares Issued
SharesIssued
4327996 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-46146 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-81677 usd
CY2023Q1 us-gaap Shares Issued
SharesIssued
4327996 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-127823 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-64876 usd
CY2023Q2 us-gaap Shares Issued
SharesIssued
4327996 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-192699 usd
CY2023Q4 us-gaap Shares Outstanding
SharesOutstanding
4327996 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-325303 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-118713 usd
CY2024Q1 us-gaap Shares Outstanding
SharesOutstanding
4327996 shares
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-444016 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-71828 usd
CY2024Q2 us-gaap Shares Outstanding
SharesOutstanding
4327996 shares
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-515844 usd
us-gaap Net Income Loss
NetIncomeLoss
-190542 usd
us-gaap Net Income Loss
NetIncomeLoss
-146553 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22691 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13955 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21390 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4800 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-30997 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10000 usd
ankm Increase Decrease In Right Of Use Assets And Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLiabilitiesNet
-14021 usd
ankm Increase Decrease In Right Of Use Assets And Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLiabilitiesNet
17596 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
184040 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-37899 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4305 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
80 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3134 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-158021 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
131400 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-131400 usd
us-gaap Proceeds From Repayment Of Loans By Employee Stock Ownership Plans
ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans
135317 usd
us-gaap Proceeds From Repayment Of Loans By Employee Stock Ownership Plans
ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans
159700 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
135317 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
159700 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
783 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1679 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2277 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1069 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3956 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
23564 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
23564 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zWtIKmU2Qy2d" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_86E_zJDxVJPk2oVj">Use of Estimates</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 us-gaap Capital Leases Contingent Rental Payments Due
CapitalLeasesContingentRentalPaymentsDue
5801 usd
CY2023Q4 us-gaap Capital Leases Contingent Rental Payments Due
CapitalLeasesContingentRentalPaymentsDue
44900 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5801 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44900 usd
CY2024Q2 ankm Project Cost
ProjectCost
6645 usd
ankm Capitalized Software
CapitalizedSoftware
130866 usd
CY2023 ankm Capitalized Software
CapitalizedSoftware
22157 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
427343 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
292026 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
551434 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
360893 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-551434 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-360893 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
115801 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
75787 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
115801 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
75787 usd

Files In Submission

Name View Source Status
0001781629-24-000014-index-headers.html Edgar Link pending
0001781629-24-000014-index.html Edgar Link pending
0001781629-24-000014.txt Edgar Link pending
0001781629-24-000014-xbrl.zip Edgar Link pending
ankm-20240531.xsd Edgar Link pending
ankm10q_31may2024.htm Edgar Link pending
exh31.htm Edgar Link pending
exh32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
ankm-20240531_cal.xml Edgar Link unprocessable
ankm-20240531_def.xml Edgar Link unprocessable
ankm-20240531_pre.xml Edgar Link unprocessable
ankm-20240531_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ankm10q_31may2024_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending